Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from GlaxoSmithKline

Treatment for Parkinson’s disease and restless leg syndrome is linked with risky behaviour – here’s what you need to know

Getting a headache and feeling sick are common side-effects for many medicines. Indulging in risky sexual behaviour or pathological gambling – not so common.

The Conversation

Pharma company funding for patient advocacy groups needs to be transparent

Patient groups should be playing a central role in Canada’s health-care system, advocating for their members by promoting the visibility of their conditions, pushing for more rapid and accurate diagnoses and lobbying for the introduction and funding of new treatments and drugs that may help relieve their members’ symptoms and…

The Conversation

RSV is linked to asthma in children – but we can’t say one causes the other yet

As winter rolls on in Australia, respiratory viruses are everywhere. One of the main culprits is respiratory syncytial virus, or RSV, which has caused more than 145,000 infections around the country so far this year. Most are in children under five.

The Conversation

From analysis to the latest developments in health,
read the most diverse news in one place.

GSK’s health is improving. Shame about the legal heartburn

Emma Walmsley’s overhaul seems to be delivering the goods even if US worries have left the share price becalmed

The Guardian - UK

Experts say Medicaid rebate change is behind inhaler price cuts - Roll Call

Three inhaler manufacturers will cap patient copays for their inhalers at $35 a month and lower the list prices of some of those products.

Roll Call

Flovent Asthma Medication Discontinued In U.S., Impacting Families

The discontinuation of childhood asthma medication Flovent in the U.S. has led to challenges with the transition to the generic version, impacting parents,...

Top News

Read news from The Economist, FT, and more,
with one subscription

Pharma giant tops new business gender equality index

‘Lead5050 Index provides a comprehensive snapshot of how well employers tackle the gender pay gap’

The Independent UK

GlaxoSmithKline tops new business gender equality index

The Equity Index 2022/23 produced by Lead 5050 ranked firms using official data on average salaries, bonuses, and pay.

The Independent UK

Lisa Jarvis: What parents can do as RSV spikes among children

A surge in cases of a common respiratory virus is filling up pediatric hospital beds around the U.S. The early and swift arrival of respiratory syncytial virus, or RSV, is stretching the limits of an already exhausted health care system. Layer on COVID and the flu, and you’ve got the…

Tribune News Service

Chemical engineer fired by pharma giant GlaxoSmithKline after racist, homophobic rant on plane

Man mentioned employer GlaxoSmithKline in rant, calling it ‘one of the best f***ing companies in the world’

The Independent UK

GlaxoSmithKline Announces $3.3 Billion Buyout To Square Off With Pfizer, Merck

GlaxoSmithKline announced Tuesday a $3.3 billion deal to buy pneumonia vaccine-maker Affinivax. But GSK stock dipped at the close.

Investors Business Daily

GlaxoSmithKline: Dividend Insights

Wednesday marks the last chance for investors to receive the next dividend payout from GlaxoSmithKline (NYSE:GSK).

Benzinga

Boots, Superdrug and other chemists report hay fever pill shortages

GlaxoSmithKline blames shortage of key ingredient for lack of Piriton and Piriteze tablets

The Guardian - UK

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

3 High-Yield Dividend Stocks to Buy in May: GlaxoSmithKline, A.P. Moeller-Maersk, and ENI

With the latest federal interest rate hike and the possibility of further monetary policy tightening, market indices have been going haywire. Because volatility is expected to persist, with experts fearing the economy will slip into recession, we think it could be wise to bet on high dividend-yielding stocks GlaxoSmithKline (GSK),…

The Guardian - UK

Radical plans to transform NHS drawn up at drug firms and No 10 roundtable

Exclusive: ideas include reducing trial safeguards and allowing startups to harvest patient data

Benzinga

Recap: GlaxoSmithKline Q1 Earnings

GlaxoSmithKline (NYSE:GSK) reported its Q1 earnings results on Wednesday, April 27, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Benzinga

GlaxoSmithKline's Earnings Outlook

GlaxoSmithKline (NYSE:GSK) is set to give its latest quarterly earnings report on Wednesday, 2022-04-27. Here's what investors need to know before the announcement. Analysts estimate that GlaxoSmithKline will report an earnings per share (EPS) of $0.76.

Get all your
news in one place.

100’s of premium titles.
One news app.

Evening Standard

GlaxoSmithKline and AstraZeneca secure victories with US drug regulator

GlaxoSmithKline’s drug aimed at chronic kidney disease patients with anaemia and AstraZeneca’s lung cancer treatment have both moved a step closer to getting the green light

Investors Business Daily

Biotech Feeding Spree As GSK, Halozyme Announce Nearly $3 Billion In Deals

GlaxoSmithKline said Wednesday it will buy Sierra Oncology for $1.9 billion, sending the biotech stock flying.

Investors Business Daily

Dow Jones Falls As Tech Dives; Twitter Rallies As Elon Musk Makes This Choice; Apple Stock Slides

The Dow Jones fell as tech dived. Twitter rallied after Tesla CEO Elon Musk chose an alternative to joining its board. Apple stock dipped.

The Guardian - UK

GlaxoSmithKline says it will not start any new clinical trials in Russia

Pharma firm joins AstraZeneca and Pfizer in saying it will not enrol new patients into studies

Benzinga

Does CBD Have To Be Water Soluble? One Group Of Scientists Say Yes For Better Absorption

Several former scientists and staff from companies like Johnson & Johnson (NYSE: JNJ), GlaxoSmithKline (NYSE: GSK) and Schiff Nutrition are bringing a new delivery platform to market that boosts the bioavailability of&

Radio France Internationale

France's Sanofi to seek Covid vaccine approval after months of delays

French pharmaceuticals giant Sanofi has said that its Covid-19 vaccine, developed with Britain's GlaxoSmithKline, had delivered positive results after nearly a year of setbacks that left it lagging far behind its rivals.

The Independent UK

New Covid vaccine 100% effective against severe disease, manufacturers say

French pharmaceutical Sanofi and its British partner GlaxoSmithKline hope their vaccine will also be used as a booster

1 2

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

325 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.